Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,194 INR | +2.50% | +5.18% | +5.27% |
Feb. 02 | Ajanta Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit | MT |
Jan. 31 | Transcript : Ajanta Pharma Limited, Q3 2024 Earnings Call, Jan 31, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.27% | 3.31B | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- AJANTPHARM Stock
- News Ajanta Pharma Limited
- Ajanta Pharma Board to Consider Second Interim Dividend for Fiscal 2024